Navigation Links
VolitionRx Finds Simple Blood Test Detects 85% of Colorectal Cancers and Over 50% of Polyps
Date:12/2/2013

NAMUR, Belgium, Dec. 2, 2013 /PRNewswire/ -- VolitionRx Limited (VNRX:OB), a life sciences company focused on developing blood-based diagnostic tests for different types of cancer, today releases new data showing that when combining two of its proprietary NuQ® assays into one test, they can achieve 85% detection rates at 85% specificity for colorectal cancer. The data also shows that Volition's two-assay test can detect more than 50% of precancerous polyps. These new findings come from its ongoing prospective study with CHU Dinant Godinne | UCL Namur Hospital in Belgium.

Earlier this month, VolitionRx presented preliminary data from a 90 patient independent trial, later confirmed in a further 113 patients, at University Hospital Bonn in Germany. This data demonstrated 75% detection rates at 70% specificity when using a single NuQ assay. The Belgian team confirmed these results using the same single assay, but when combining it with another nucleosome biomarker they achieved even better results. They have now analysed 39 patients' samples from the ongoing prospective trial which includes both healthy patients and patients with benign colon disorders.

"This increased detection rate confirms our original hypothesis that combining nucleosomes increases the accuracy of the test," comments Dr. Jake Micallef, Chief Scientific Officer of VolitionRx.  "We hope to further increase the sensitivity and specificity by adding more biomarkers and developing a larger panel of nucleosome tests."

Current diagnostic screening practices for colorectal cancer vary globally, from inviting at-risk groups to submit faecal occult blood tests to offering regular investigative colonoscopies. Unfortunatel
'/>"/>

SOURCE VolitionRx Limited
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. VolitionRx Expands Sample Size to 11,000 in Pivotal Colorectal Cancer Trial with Hvidovre Hospital, Denmark
2. VolitionRx-led Consortium Awarded euro 780 000 ($1M approx.) Eurostars Grant
3. VolitionRx Embarks on Colorectal Cancer Trial with Hvidovre Hospital, Denmark
4. VolitionRxs Preliminary Diagnostic Clinical Trial Results Show High Sensitivity and Specificity for Colon, Breast and Lung Cancers
5. International Survey Finds Self-Administered Treatment on the Rise Among Hereditary Angioedema Patients
6. Report Finds Healthcare Sales Job Openings are Down but Increasing
7. BioInformatics LLC—New Report Finds High Degree of Satisfaction With Instrumentation Performance Among Researchers
8. Study finds plasmin -- delivered through a bubble -- more effective than tPA in busting clots
9. Preliminary Research, Led By Dr. Vincent Giampapa, Finds Aged Adult Stem Cells Can Be Functionally Reprogrammed To Act Like Younger Cells
10. PwCs Health Research Institute Finds Shortage of Health IT Workers Could Slow Industry Progress
11. EU Study Finds UK Health Product Benefit Metric Flawed
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/29/2015)... 29, 2015 Delcath Systems, Inc. (NASDAQ: ... device company focused on oncology with an emphasis ... cancers, announces that results of a large, European ... patients with hepatic metastases with the Delcath Hepatic ... an on-line abstract at the American Society of ...
(Date:5/29/2015)... RESEARCH TRIANGLE PARK, N.C. , May 29, ... announced today that Roger Jeffs , Ph.D., President and ... and update on the company,s business at the Jefferies 2015 ... . The presentation and the immediately following Q&A ... 11:00 AM Eastern Time, and can be accessed via a ...
(Date:5/28/2015)... 2015 Research and ... addition of Jain PharmaBiotech,s new report ... Companies" to their offering. ... report deals with therapeutic drug monitoring, a ... care by monitoring drug levels in the ...
(Date:5/28/2015)... , May 27, 2015 Research and ... Jain PharmaBiotech,s new report "Cell Therapy - ... This report describes and evaluates cell ... to play an important role in the practice ... the old fashioned bone marrow transplants. Role of ...
Breaking Biology Technology:Positive Data With Delcath's CHEMOSAT Highlighted At ASCO 2015 2Positive Data With Delcath's CHEMOSAT Highlighted At ASCO 2015 3Positive Data With Delcath's CHEMOSAT Highlighted At ASCO 2015 4Positive Data With Delcath's CHEMOSAT Highlighted At ASCO 2015 5Global Therapeutic Drug Monitoring Market 2015-2024 2Global Cell Therapy Market 2015-2020 - Technologies, Markets and Companies 2
... , There,s good news in the search for ... U.S. Department of Energy,s Lawrence Berkeley National Laboratory ... Berkeley, have successfully integrated ultra-thin layers of the ... create a nanoscale transistor with excellent electronic properties. ...
... Crescent Healthcare today announced a planned expansion of their ... to open an infusion pharmacy in Totowa, New Jersey, ... current patients in Massachusetts, Maryland, New York, New Jersey, ... In addition to supporting current business ...
... 2010 Reportlinker.com announces that a new market ... Global Bladder Cancer Therapeutics Industry ... report analyzes the worldwide markets for Bladder Cancer ... comprehensive analytics for US, Japan, Europe, and Rest ...
Cached Biology Technology:Ultrathin alternative to silicon for future electronics 2Ultrathin alternative to silicon for future electronics 3Crescent Healthcare Expands East Coast Presence 2Reportlinker Adds Global Bladder Cancer Therapeutics Industry 2Reportlinker Adds Global Bladder Cancer Therapeutics Industry 3Reportlinker Adds Global Bladder Cancer Therapeutics Industry 4Reportlinker Adds Global Bladder Cancer Therapeutics Industry 5Reportlinker Adds Global Bladder Cancer Therapeutics Industry 6Reportlinker Adds Global Bladder Cancer Therapeutics Industry 7Reportlinker Adds Global Bladder Cancer Therapeutics Industry 8Reportlinker Adds Global Bladder Cancer Therapeutics Industry 9Reportlinker Adds Global Bladder Cancer Therapeutics Industry 10Reportlinker Adds Global Bladder Cancer Therapeutics Industry 11Reportlinker Adds Global Bladder Cancer Therapeutics Industry 12Reportlinker Adds Global Bladder Cancer Therapeutics Industry 13
(Date:5/8/2015)... 8, 2015 Synaptics Inc. (NASDAQ: SYNA ), ... members of the executive management team will present at the ... Media and Telecom Conference Date: May 18, 2015 ... Boston, MA Cowen and Company Technology, ... ET Location: The New York Palace Hotel, New ...
(Date:5/5/2015)... OXFORD, Conn. , May 5, 2015, NXT-ID, ... biometric authentication company focused on the growing mobile commerce market, ... the Company,s Chief Technology Officer, is presenting  at CARTES SECURE ... May 5-7, 2015. The three-day conference ... session David is speaking in is themed Global Fraud: ...
(Date:4/27/2015)... 2015 Profile Solutions, Inc. (OTC: PSIQ), a ... is pleased to announce that Dr Gerry Bedore ... member of its scientific advisory board. ... thought leader in technology-enhanced learning models. He was a ... published studies and books focused on online student success ...
Breaking Biology News(10 mins):Synaptics to Present at Upcoming Investor Conferences 2NXT-ID, Inc.'s CTO, David Tunnell, Presents at CARTES SECURE CONNEXIONS AMERICA 2015 Today in Washington DC. 2NXT-ID, Inc.'s CTO, David Tunnell, Presents at CARTES SECURE CONNEXIONS AMERICA 2015 Today in Washington DC. 3Profile Solutions Names Medicinal Cannabis, Agriculture and Technology Expert Dr. Gerry Bedore to its Scientific Advisory Board 2Profile Solutions Names Medicinal Cannabis, Agriculture and Technology Expert Dr. Gerry Bedore to its Scientific Advisory Board 3Profile Solutions Names Medicinal Cannabis, Agriculture and Technology Expert Dr. Gerry Bedore to its Scientific Advisory Board 4
... , Non-melanoma skin cancer is the most common form of ... cases recorded each year in the USA alone. ... these cancers is continuously rising due mainly to the aging ... prosperity, permitting more visits to countries with high sun exposure, ...
... at the Stuttgart Natural History Museum were leading in the ... of South America. The spectacular fossils were named Coxoplectoptera ... a special issue on Cretaceous Insects in the scientific journal ... group led by Dr. Arnold H. Staniczek and Dr. Gnter ...
... scientists have defined the structure -- down to the atomic ... research may help direct efforts to develop medications that block ... by Professor Yizhi Jane Tao, postdoctoral researcher Jinhui Dong and ... Proceedings of the National Academy of Sciences . ...
Cached Biology News:Some cutaneous HPV types may be involved in non-melanoma skin cancer development 2Juvenile diarrhea virus analyzed 2Juvenile diarrhea virus analyzed 3